Risk of COVID-19 infection in MS and neuromyelitis optica spectrum disorders
Conclusions
No increased risk of COVID-19 infection was observed in patients with MS or NMOSD, irrespective of whether these patients received DMDs. A battery of stringent preventive measures adopted by neurologists to reduce COVID-19 infection in these patients may have contributed to low risk of COVID-19 infection.
Source: Neurology Neuroimmunology and Neuroinflammation - Category: Neurology Authors: Fan, M., Qiu, W., Bu, B., Xu, Y., Yang, H., Huang, D., Lau, A. Y., Guo, J., Zhang, M.-N., Zhang, X., Yang, C.-S., Chen, J., Zheng, P., Liu, Q., Zhang, C., Shi, F.-D. Tags: Autoimmune diseases, All Clinical Neurology, All Demyelinating disease (CNS), Multiple sclerosis, Devic's syndrome Article Source Type: research
More News: Autoimmune Disease | Brain | China Health | Coronavirus | COVID-19 | Multiple Sclerosis | Neurology | Pneumonia | Respiratory Medicine | SARS | Study